From scattered data to a decision you can defend.
Three of the ways you could work with ISG. Each engagement is scoped to the question in front of you, and each ends with something your team can act on.
All three are billed hourly against an estimate agreed before work starts. Typical shapes: a written POV in two to three weeks — a recent phase covered thirty-one extracted studies in sixteen days. A full mechanism-and-ingredient mapping project runs six to ten weeks across three or four stages.
Discovery
Find the opportunity worth pursuing, and the evidence that supports it.
At ISG, our Discovery phase kicks off by aligning with your strategic goals, benefit-areas and innovation intent. We investigate global research, market trends, competitive landscapes and emerging ingredient and technology opportunities — converting a wide span of scattered data into focused, actionable claim maps and whitespace innovation zones.
At early stage innovation, when you're exploring new directions, validating markets, or reevaluating R&D funnel priorities.
Scientific Deep Dive
A structured PICO read on what the published evidence can and cannot support, accelerated by Evidentia Engine.
Our Scientific Deep Dive service brings a rigorous evidence-based lens. We deploy a structured PICO (Population, Intervention, Comparator, Outcome) methodology to assess the quality, consistency and relevance of published studies — clarifying where claim potential exists and where evidence falls short.
When you have an ingredient or technology in mind and need to validate its evidence base, or when you need to structure scientific output into business language for claims, regulatory, or marketing review.
Technology Optimization
Streamline the engine that turns science into claims — including Evidentia Engine, the machine-learning layer behind the deep dive.
The Technology Optimization service is about streamlining your science and innovation engine: refining processes, ensuring scientific integrity, improving efficiency, and integrating technology platforms where needed.
When you're operating at scale, or your innovation and claim-development team feels inefficient or disconnected — and you need to optimize how science becomes claims and opportunities.
Same arc, whatever the question.
Scope and duration follow the question. The sequence does not: frame it, interrogate the evidence, and leave your team with a decision they can defend.
Frame the question
Align on the decision at stake, the benefit area, and what an answer has to survive — regulatory review, a claim, a board.
Interrogate the evidence
Structured PICO review of the published record, with strength tiering and the gaps named as plainly as the support.
Build the decision path
Translate the science into the call in front of you: pursue, redesign, substantiate further, or walk away — and what it takes.
Timelines shown are typical. Discovery sprints run shorter; research programs run longer.
What you actually get.
An R&D Evidence Point of View states where an ingredient can carry a claim today, where it cannot, and what it would take to change that. Every assessment is measured against one written standard, so the answer is auditable rather than an opinion.
21 trial observations from 12 studies in healthy women aged 41–65, tested across four benefit areas against an explicit standard for claim readiness.
Net point of view. Black cohosh is claim-ready for menopausal symptom support and for stress and mood management. Sleep and metabolic support warrant further research investment; the evidence does not support positioning it as a multi-benefit claim-ready platform.
Excerpt from a client deliverable. Client name and full evidence tables removed.
Examples of what arrives.
Deliverables are shaped to the question, so no two engagements produce quite the same set. These are examples of forms the work has taken. Client names, and in some cases the subject matter, stay confidential.
Start where it hurts.
Tell us the question and what hangs on it. We will come back with how we would approach it, what it would take, and whether we are the right people for it.
Start a conversation